Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
86 Cards in this Set
- Front
- Back
Decreases thrombin and Xa, short half-life -- used for immediate anticoagulation for pulmonary embolism, stokre, acute coronary syndrome, MI, DVT.
1. major mechanism 2. follow what lab? |
Heparin
1. catalyzes the activation of antithrombin III 2. PTT |
|
Protamine sulfate is used for the rapid reversal of the effects of what drug?
1. mechanism |
Heparin
1. positively charged molecule that acts by binding negatively charged heparin |
|
act more on Xa, and can be administered without lab monitoring of PTT
1. problem |
low-molecular weight heparins (i.e. ENOXAPARIN)
1. not easily reversible |
|
binds platelets causing autoantibody production that destroys platelets and overactivates the remaining ones, resulting in a thrombocytopenic, hypercoagulable state
|
Heparin causing Heparin-induced thrombocytopenia (HIT)
|
|
Pathogenesis of HIT
|
1. Heparin binds PLT factor 4 to form heparin:PF4 complex
2. Igs form against that complex -- autoantibody production leads to destruction of PLTs and activation of platelets --> thrombocytopenia AND hypercoagulable state |
|
Hirudin derivatives; directly inhibit thrombin
1. used for |
Lepirudin, bivalirudin
1. alternative to heparin for anticoagulating patients with HIT |
|
Alternative to anticoagulating patients with HIT
1. mechanism |
Lepirudin, bivalrudin
1. directly inhibits thrombin |
|
Has a long half-life. Requires monitoring of PT.
1. mechanism 2. how metabolized? |
Warfarin
1. interferes with normal synthesis of gamma-carboxylation of vitamin K-dependent clotting factors II, VII, IX, X, PC, and PS. 2. cytochrome P450 |
|
Affects the extrinsic pathway
1. clinical use 2. huge contraindication |
Warfarin
1. Chronic anticoagulation 2. pregnancy -- because it crosses the placenta |
|
Toxicities include bleeding, teratogenesis, skin/tissue necrosis, and drug-drug interactions.
|
Warfarin
|
|
Acetylates and irreversibly inhibits COX 1 and 2 preventing what process which promotes platelet aggregation:
1. has what effect on PT, PTT, bleeding time? |
Aspirin (ASA)
inhibition of COX prevents conversion of arachidonic acid to TXA2 which promotes PLT aggregation 1. No effect on PT, PTT, but increases bleeding time |
|
Toxicities include gastric ulceration, bleeding, hyperventilation, Reye's syndrome, and tinnitus (CN VIII)
1. clinical use |
Aspirin (ASA)
1. antipyretic, analgesic, anti-inflammatory, antiplatelet |
|
Inhibit PLT aggregation by irreversibly blocking ADP receptors.
1. inhibit PLT binding to fibrinogen how? |
Clopidogrel, ticlopidine
1. prevent glycoprotein G2b/3a from being expressed |
|
Monoclonal antibody that binds to glycoprotein receptor 2b/3a on activated platelets, preventing aggregation
1. toxicities |
Abciximab
1. bleeding, thrombocytopenia |
|
Used for acute coronary syndrome; coronary stenting. decreases the incidenece or recurrence of thrombotic stroke
1. toxicity |
Clopidogrel, ticlopidine
1. Neutropenia (tocloopidine) |
|
used for acute coronary syndromes, percutaneous transluminal coronary angioplasty, monoclonal antibody
1.mechanism |
Abciximab
1. antibody to Gp2b/3a mimicking Glanzmann's disease |
|
Pyrimidine analog bioactivated to a form that covalently complexes folic acid. This complex inhibits thymidylate synthease resulting in a decrease in dTMP
1. Toxicity |
5-fluorouracil bioactivated to 5F-dUMP
1. myelosuppresion which is not reversible with leucovorin, photosensitivity |
|
Thymidine is administered to "rescue" the patient from this treatment
1. mechanism |
5-fluorouracil
1. bioactivated to 5F-dUMP which complexes with folic acid, this complex inhibits thymidylate synthase |
|
Blocks de novo purine synthesis. activated by HGPRTase.
1. toxicity 2. metabolized by: |
6-MP (mercaptopurine)
1. bone marrow, GI, liver. 2. xanthine oxidase |
|
Toxicity increased with allopurinol, why?
|
6-MP
b/c allopurinol inhibits xanthine oxidase which metabolizes 6-MP |
|
what is histiocytosis X?
|
proliferative disorder of dendritic langerhan cells from the monocyte lineage
|
|
What is the site of action for Warfarin & Heparin?
|
Warfarin acts in the liver
Heparin acts in the blood |
|
Describe the onset of action of Heparin vs. Warfarin
|
heparin is raid in seconds
Warfarin is slow, limiedt by half lives of normal clotting factors |
|
what is the limit of Warfarin's onset of effectiveness?
|
the half lives of normal clotting factors
|
|
What is the duration of action for Heparin & warfarin?
|
Hep has acute hours
Warfar has chronic (days) |
|
Which inhibits coagulation in vitro Heparin or warfarin?
|
Heparin
|
|
What is the treatment of acute overdose of warfarin?
|
IV vitamin K & Fresh frozen plasma
Remember that Vit K will give you protein C & S faster so dont give Vit K first if their INR is real high |
|
Which crosses the palcenta Warfarin or heparain?
|
Warfarin is teratogenic
|
|
how do thrombolytics affect PT & PTT?
|
they increase both because they are acting on the process which converts plasminogen to plasmin which breaks down the clot formed by either the intrinsic or extrinsic pathway
|
|
What is the clinical use for thrombolytics?
when are the contraindicated? |
1. Early Mi
2. ischemic stroke they are contraindicated in people with bleeding issues or sever HTN |
|
What is urokinase and what endogenous compound is it similar to in its action?
|
urokinase is a thrombolytic and does the same thing as tPA
|
|
What is aminocaproic acid?
|
This is an antithrombolytic that inhibits the conversion of plasminogen to plasmin
|
|
How does streptokinase affect clotting?
|
Streptokinase combines with a proactivator and converts plasminogen to plasmin which breaks down the clot
|
|
How does anistreplase (APSAC) affect clotting?
|
Anestreplase converts plasminogen to plasmin
|
|
Synergy with MTX, why?
|
5-FU -- b/c it inhibits thymidylate synthase, which also prevents the synthesis of dTMP
MTX works by inhibiting dihydrofolate reductase so that it can't regenerate the THF that is needed to make dTMP from dUMP |
|
converted to a nucleotide analog that inhibits DNA polymerase
1. toxicities |
Cytarabine (ara-C)
converted to cytosine arabimoside triphosphate 1. megaloblastic anemia, luekopenia, thrombocytopenia |
|
toxicities include leukopenia, thrombocytopenia, megaloblastic anemia
|
Cytarabine (C-ara)
1. inhibits DNA polymerase -- converted to cytosine arabinoside triphosphate |
|
Alkylating agents that covalently cross-link DNA at guanine N-7
1. require bioactivation by: |
Cyclophosphamide, ifosfamide
1. liver |
|
Methotrexate is an antimetabolite and inhibits what phase of the cell cycle?
|
s phase
|
|
What drug inhibits dyhydrofolate reductase?
|
Methotrexate (it's a folate analog)
|
|
what drug is a folic acid analogue?
|
methotrexate
|
|
What is leucovorin (folinic acid)?
|
this is used with methotrexate to reverse its myelosuppressive effects.
It works by replacing folic acid. It is a metabolite that does not need to be acted on by dihydrofolate reductase so it can still be used and some DNA synth can occur? |
|
What thrombolytic comes from beta-hemolytic strep?
|
streptokinase
|
|
What is the toxicity of methotrexate?
|
myelosuppression
|
|
What is the mechanism of action of Busulfan?
1. toxicity |
it alkylates DNA
1. pulmonary fibrosis and hyperpigmentation |
|
What 2 drugs can cause pulmonary fibrosis?
|
1. Busulfan
2. Bleomycin |
|
What drug causes Hyper pigmentation?
|
Busulfan
|
|
what drugs have a red color?
|
Doxorubicin (adriamycin, daunorubicin
think RUBY red |
|
Mechanism of Doxorubicin (adriamycin)?
|
generates free radicals & noncovalently intercalates in to DNA (this creates breaks in DNA strand to decrease replication)
|
|
What drug non-covalently intercalates into DNA?
|
Doxyrubicin/adriamycin
(also generates free radicals) |
|
What drug is cardiotoxic and causes toxic extravasation?
what other toxicities? |
Doxorubicin/adriamycin
alopeicia + myelosupression |
|
What is the mechanism for Dactinomycin (actinomycin)D?
toxicitiy? (its pretty standard) |
intercaltes into DNA
myelosuppression |
|
What is the mechanism for bleomycin?
|
induces formation of free radicals, which cause breaks in DNA strands
|
|
What is the mechanism for hydroxyurea? & what phase of cell cylce is affected?
|
inhibts ribonucleotide reductase t/f DNA synthesis decreases
affects S phase |
|
What is the mechanism for Etoposide (VP-16)? what phase of cell cylce?
|
G2 phase and S phase specific agent that inhibits topoisomerase 2 & increases DNA degredatoin
|
|
What is the mechanism for Prednisone?
|
may trigger apoptosis (but may work on undividing cells)
|
|
What is the mechanism for Tamoxifen / raloxifene? how does it help women (2 different ways)?
|
this is a SERM which is an estrogen receptor modulator
It acts as an estrogen antagonist in breast & agonist in the bone |
|
what drug inhibits topoisomerase 2?
|
Etoposide (VP-16)
|
|
What is the toxicity of tamoxifen? how is it different from raloxifene?
|
increase risk of endometrial carcinoma due to its agonist effects
also causes hot flashes Raloxifene does not increase risk for endometrial carcinoma because its an endometrial agonist |
|
What drug can cause Cushing's like symptoms, acen, immunosuppression, cataracts, acne?
|
prednisone
|
|
what drug can cause hyperglycemia?
|
prednisone
|
|
what drug can cause GI ulcers & psychosis?
|
prednisone
|
|
Hydroxyurea is used in CML and what other non-cancer disease?
|
sickle cell b/c it increases fetal Hb
|
|
Does bleomycin cause myelosuppresion?
|
No daddy, it doesnt
|
|
Bleomycin inhibits what phase of the cell cycle?
|
G2 phase
|
|
cause hemorrhagic cystitis
1. which can partially be prevented with: |
Cyclophosphamide, ifosfamide
1. mesna (sulfhydryl groups of mesna bind the intermediate metabolite acrolein which is toxic to the bladder) |
|
Cause myelosuppresion, which is why they are sometimes used as immunosuppressants
|
Cyclophophamide, ifosfamide
|
|
Alkylate DNA, but require bioactivation. cross the blood-brain barrier which is why they are used for brain tumors (including glioblastoma multiforme)
|
Nitrosoureas
Carmustine, lomustine, semustine, streptozocin |
|
cause CNS toxicity (dizziness, ataxia) used for brain tumors
1. mechanism |
Nitrosoureas -- Carmustine, lomustine, semustine, streptozocin
1. alkylating agents that require bioactivation, cross blood-brain barrier |
|
Carmustine, lomusstine, semustine, streptozocin
1. mechanism |
Nitrosoureas
1. alkylate DNA, cross blood-brain barrier |
|
Cross-link DNA -- cause nephrotoxicity and acoustic nerve damage
|
Cisplatin, carboplatin
|
|
used for testicular, bladder, ovary, and lung carcinomas
1. cross-link DNA |
Cisplatin, carboplatin
1. mechanism |
|
Monoclonal antibody against HER-2 (erb-B2)
1. helps kill breast cancer cells that: |
Trastuzumab
1. overexpress HER-2, possibly through antibody-dependent cytotoxicity |
|
causes cardiotoxicity, used for metastatic breast cancer
1. mechanism |
Trastuzumab (Herceptin)
1. monoclonal antibody against HER-2 (erb-B2) which is expressed on breast cancer cells |
|
Philadelphia chromosome bcr-abl tyrosine kinase inhibitor
1. toxicity |
Imatinib (Gleevec)
1. fluid retention |
|
used for CML, GI stromal tumors
1. mechanism |
Imatinib (Gleevec)
1. Philadelphia chrosome bcr-abl tyrosine kinase inhibitor |
|
M-phase specific alkaloids that bind tubulin and block polymerization of microtubules so that mitotic spindle cannot form
1. toxicities |
Vincristine, vinblastine
1. vincristine --> neurotoxicity (areflexia, peripheral neuritis, paralytic ileus 2. vinblastine --> bone marrow suppression (Blast = Bone marrow |
|
causes neurotoxicity (areflexia, peripheral neuritis), paralytic ileus
1. mechanism |
Vincristine
1. M-phase specific alkaloid that binds tubulin and blocks polymerization of microtubules so that mitotic spindle cannot form |
|
bone marrow suppression, M-phase-specific alkaloid
|
vinBLASTine BLASTS the bone marrow
|
|
M-phase-specific agents that bind to tubulin and hyperstabilize polymerized microtubules so that mitotic spindle cannot break down (anaphase cannot occur)
1. toxicities |
Paclitaxel, other taxols
1. myelosuppresion and hypersensitivity |
|
causes myelosuppression and hypersensitivity
|
Paclitaxel, other taxols
|
|
prevents anaphase from occuring
|
Paclitaxel, other taxols
|
|
Cladribine is used for:
1. Mechanism |
Hairy cell leukemia
1. cytotoxic purine resistant to degradation by Adenosine deaminase |
|
What drug limits the nephrotoxicity caused by Cisplatin?
What is the mechanism? |
Amifostine
Scavenges free radicals |
|
What limits the cardiotoxicity of Doxo/Daunorubicin?
What is the mechanism? |
Dexrazoxane
Iron-chelating agent |
|
Leucovorin can be used to potentiate the toxicity of which drug?
|
Leucovorin strengthens the association of 5-FU with thymidylate synthase
|